The Effect on Envelope of Motion in Asymptomatic Bruxers
NCT ID: NCT05604729
Last Updated: 2023-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2023-09-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Changes in Electromyographic Activity in Aligner Treatment of Adult Patients With and Without Nocturnal Bruxism
NCT06343194
Behavioral Interventions for Controlling Oral Behaviors
NCT07022795
Which is More Effective in Management of Bruxism: Botox or Occlusal Splints
NCT04366869
Reduction of Masticatory Muscle Activity by Restoring Canine Guidance
NCT02235220
Effect of Shock Waves on Tooth Movement and Miniscrew Stability
NCT01695928
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BoNT A (botulinum neurotoxin type A)
Botulinum neurotoxin, 25 units (U) into each masseter at three sessions.
Botulinum toxin type A
Botulinum Neurotoxin type A
Placebo
Saline solution
Placebo
Saline solution
Control
Saline solution, no tooth wear
Placebo
Saline solution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Botulinum toxin type A
Botulinum Neurotoxin type A
Placebo
Saline solution
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* No drugs affecting the central nervous system.
* No conditions affecting muscles or central nervous system.
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Umeå University
OTHER
Region Västerbotten
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mattias Pettersson, PhD
Role: PRINCIPAL_INVESTIGATOR
Umeå University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Norrlands universitetssjukhus
Umeå, Västerbotten County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BoNT A - Morphology
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.